Clinical Trials Logo

IDH1 wt Allele clinical trials

View clinical trials related to IDH1 wt Allele.

Filter by:
  • None
  • Page 1

NCT ID: NCT03896568 Recruiting - Clinical trials for Recurrent Glioblastoma

MSC-DNX-2401 in Treating Patients With Recurrent High-Grade Glioma

Start date: February 12, 2019
Phase: Phase 1
Study type: Interventional

This phase I trial studies best dose and side effects of oncolytic adenovirus DNX-2401 in treating patients with high-grade glioma that has come back (recurrent). Oncolytic adenovirus DNX-2401 is made from the common cold virus that has been changed in the laboratory to make it less likely to cause an infection (such as a cold). The virus is also changed to target brain cancer cells and attack them.